Yet, since the patients with un-SpA may over time evolve to an overt disease, more specifically into PsA and arthritis related to IBD, the presence of HLA-B*35 should, in rheumatologists, raise awareness of the possible development of psoriasis and IBD or even the existence of subclinical inflammatory lesions in the gut. This evidence concerns the gene HLA-B and inflammatory bowel disease.